Company profileNutraceutical & supplements#77 of 1,318 in Pakistan✓ No DRAP alerts

ABS Pharma (Alaq-Biosciences), District Sheikhupura

Nutraceutical & supplement manufacturer · 194 registered products

Ranked #7 of 13 companies in Anaesthetic, General

194 registered products 9 distinct molecules 0 DRAP alerts
194 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

194
registered products
9
distinct molecules
1
therapeutic classes
0
DRAP alerts

ABS Pharma (Alaq-Biosciences), District Sheikhupura is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 194 product registrations. It is the 77th largest registrant in Pakistan by product count, and ranks 7th of 13 in Anaesthetic, General. Its portfolio is concentrated in Anaesthetic, General. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by ABS

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anaesthetic, General 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

1
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
20251

Top molecules by brand count

Nutritional Supplement / Multivitamin194 brands
Pyridoxine1 brand
Riboflavin1 brand
Thiamine1 brand
Ketamine1 brand
Ketamine ...... 500 Mg1 brand

Therapeutic classes

Anaesthetic, General · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 190.33 – Rs 190.33
Median across source: Rs 190.33

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Pharmasol (Pvt) Ltd. holds 114 molecules not in this portfolio
AcetazolamideAcyclovirAlpha KetoanaloguesAnastrazoleAnastrozoleAprepitant
VISION PHARMACUETICALS holds 2 molecules not in this portfolio
ChloridePotassium Chloride
Global Pharmaceuticals Pakistan holds 144 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin

Get the full profile for ABS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.